Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome.
Flørenes VA, Maelandsmo GM, Faye R, Nesland JM, Holm R. Flørenes VA, et al. J Pathol. 2001 Dec;195(5):530-6. doi: 10.1002/path.1007. J Pathol. 2001. PMID: 11745687
Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression.
Flørenes VA, Aamdal S, Myklebost O, Maelandsmo GM, Bruland OS, Fodstad O. Flørenes VA, et al. Cancer Res. 1992 Nov 1;52(21):6088-91. Cancer Res. 1992. PMID: 1356624
Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas--relationship to amplification and mRNA levels of CDK4 and CCND1.
Maelandsmo GM, Berner JM, Flørenes VA, Forus A, Hovig E, Fodstad O, Myklebost O. Maelandsmo GM, et al. Among authors: florenes va. Br J Cancer. 1995 Aug;72(2):393-8. doi: 10.1038/bjc.1995.344. Br J Cancer. 1995. PMID: 7640224 Free PMC article.
Accumulation of p53 protein in human malignant melanoma. Relationship to clinical outcome.
Flørenes VA, Holm R, Fodstad O. Flørenes VA, et al. Melanoma Res. 1995 Jun;5(3):183-7. doi: 10.1097/00008390-199506000-00007. Melanoma Res. 1995. PMID: 7640520
TP53 allele loss, mutations and expression in malignant melanoma.
Flørenes VA, Oyjord T, Holm R, Skrede M, Børresen AL, Nesland JM, Fodstad O. Flørenes VA, et al. Br J Cancer. 1994 Feb;69(2):253-9. doi: 10.1038/bjc.1994.48. Br J Cancer. 1994. PMID: 7905277 Free PMC article.
Expression of the neuroectodermal intermediate filament nestin in human melanomas.
Flørenes VA, Holm R, Myklebost O, Lendahl U, Fodstad O. Flørenes VA, et al. Cancer Res. 1994 Jan 15;54(2):354-6. Cancer Res. 1994. PMID: 8275467
Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas.
Maelandsmo GM, Flørenes VA, Hovig E, Oyjord T, Engebraaten O, Holm R, Børresen AL, Fodstad O. Maelandsmo GM, et al. Among authors: florenes va. Br J Cancer. 1996 Apr;73(8):909-16. doi: 10.1038/bjc.1996.181. Br J Cancer. 1996. PMID: 8611425 Free PMC article.
Cyclin kinase inhibitor p21WAF1/CIP1 in malignant melanoma: reduced expression in metastatic lesions.
Maelandsmo GM, Holm R, Fodstad O, Kerbel RS, Flørenes VA. Maelandsmo GM, et al. Among authors: florenes va. Am J Pathol. 1996 Dec;149(6):1813-22. Am J Pathol. 1996. PMID: 8952518 Free PMC article.
Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mts1) ribozyme.
Maelandsmo GM, Hovig E, Skrede M, Engebraaten O, Flørenes VA, Myklebost O, Grigorian M, Lukanidin E, Scanlon KJ, Fodstad O. Maelandsmo GM, et al. Among authors: florenes va. Cancer Res. 1996 Dec 1;56(23):5490-8. Cancer Res. 1996. PMID: 8968106
Differential expression patterns of S100A2, S100A4 and S100A6 during progression of human malignant melanoma.
Maelandsmo GM, Flørenes VA, Mellingsaeter T, Hovig E, Kerbel RS, Fodstad O. Maelandsmo GM, et al. Among authors: florenes va. Int J Cancer. 1997 Aug 22;74(4):464-9. doi: 10.1002/(sici)1097-0215(19970822)74:4<464::aid-ijc19>;2-9. Int J Cancer. 1997. PMID: 9291441